Microtubule-associated protein tau is a substrate of ATP/Mg 2+-dependent proteasome protease system

Journal of Neural Transmission

Volumn 112, Issue 4, 2005, Pages 547-555

  Zhang, J Y ^a   Liu, S J ^a   Li, H L ^a   Wang, J Z ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; ATP; Proteasome; Tau; Ubiquitin

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN EXTRACT; DODECYL SULFATE SODIUM; EPITOPE; LACTACYSTIN; MAGNESIUM CHLORIDE; PROTEASOME; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; ENZYME ACTIVATION; ENZYME INHIBITORS; MAGNESIUM; MICROTUBULES; NEURONS; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS; UBIQUITIN;

EID: 17644416738     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0196-x     Document Type: Article

References (25)

1. Akopian TN, Kisselev AF, Goldberg AL (1997) Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J Biol Chem 272: 1791-1798
2. Alonso Adel C, Grundke-Iqbal I, Iqbal K (1995) Bovine and human tau, highly homologous but less crossreactive: implications for Alzheimer disease. Brain Res Mol Brain Res 31(1-2): 194-200
3. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2000) Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485: 87-93
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
5. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantin MG (2002) Proteasomal degradation of tau protein. J Neurochem 83: 176-185
6. Dick LR, Cruikshank AA, Destree T, Greiner L, McCormack TA, Melandri FD, Nunes SL, Palombella VJ, Parent LA, Plamondon L, Stein RL (1997) Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem 272: 182-188
7. Goedert M, Ghetti B, Spillantini MG (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurodegenerative process. Ann NY Acad Sci 920: 74-78
8. Goldbaum O, Oppermann M, Handschuh M, Dabir D, Zhang B, Forman MS, Trojanowski JQ, Lee VM, Richter-Landsberg C (2003) Proteasome inhibition stabilizes Tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J Neurosci 23: 8872-8880
9. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899
10. Gregori L, Fuchs C, Figueiredo-Pereira ME, Van Nostrand WE, Goldgaber D (1995) Amyloid beta protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem 270: 19702-19708
11. Grundke-Iqbal I, Vorbrodt AW, Iqbal K, Tung YC, Wang GP, Wisniewski HM (1988) Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Brain Res 464: 43-52
12. Hutton M, Lendon CL, Rizzu P, et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705
13. Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm [Suppl] 53: 169-180
14. Keck S, Nitsch R, Grune T, Ullrich O (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 85: 115-122
15. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer's disease. J Neurochem 75: 436-439
16. Kudo T, Iqbal K, Ravid R, Swaab DF, Grundke-Iqbal I (1994) Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res 639: 1-7
17. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci USA 97: 9902-9906
18. Lopez Salon M, Pasquini L, Besio Moreno M, Pasquini JM, Soto E (2003) Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp Neurol 180: 131-143
19. Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235: 1641-1644
20. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10: 1151-1160
21. Shimura H, Schwartz D, Gygi SP, Kosik KS (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated Tau and enhances cell survival. J Biol Chem 279: 4869-4887
22. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J 19: 94-102
23. van Leeuwen FW, Burbach JP, Hol EM (1998) Mutations in RNA: a first example of molecular misreading in Alzheimer's disease. Trends Neurosci 21: 331-335
24. van Leeuwen FW, de Kleijn DP, Van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279: 242-247
25. Varshavsky A (1997) The ubiquitin system. Trends Biochem Sci 22: 383-387